Ginsenoside Rg2 protects cardiomyocytes against trastuzumab-induced toxicity by inducing autophagy

Trastuzumab (TZM) significantly improves the outcomes of patients with breast cancer; however, it is associated with severe cardiotoxicity. Ginsenoside Rg2 was reported to exert protective effects against myocardial injury and apoptosis in human cardiomyocytes (HCMs). However, whether ginsenoside Rg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guang, Qi, Xiaoyong, Li, Xingtao, Sun, Fangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976377/
https://www.ncbi.nlm.nih.gov/pubmed/33767768
http://dx.doi.org/10.3892/etm.2021.9904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976377/
https://www.ncbi.nlm.nih.gov/pubmed/33767768
http://dx.doi.org/10.3892/etm.2021.9904

Ejemplares similares